Samuele Butera - 23 Jun 2026 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: SVP, GM, Global Respiratory
Issuer ticker: INSM
Reported as of: 23 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jun 2026, 16:15:23 UTC
Source filing: View source filing
Reporting owner signature: /s/ Samuele Butera, by Michael A. Smith as Attorney-in-fact

Key filing fact

Samuele Butera filed Form 4 for INSMED Inc (INSM) on 24 Jun 2026.

Key facts

This page summarizes Samuele Butera's Form 4 filing for INSMED Inc (INSM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2026, 16:15.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002140098 Primary reporting owner

Butera Samuele

Relationship: SVP, GM, Global Respiratory
Address: 700 US HIGHWAY 202/206, BRIDGEWATER
Signature: /s/ Samuele Butera, by Michael A. Smith as Attorney-in-fact
Signature date: 24 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Award

Transaction value
Shares: +7,342
Change %
Price
Shares after: 7,342
Date: 23 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSM transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +12,570
Change %
Price: $0.000000^*
Shares after: 12,570
Date: 23 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,570
Exercise price: $102.15
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

Footnote F2

Each RSU was granted on June 23, 2026, for no consideration.

Footnote F3

These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.